Large‐vessel vasculitis induced by pegfilgrastim and immune checkpoint inhibitor in a patient with small‐cell lung cancer

Large‐vessel vasculitis induced by pegfilgrastim and immune checkpoint inhibitor in a patient with small‐cell lung cancer

Abstract A 75‐year‐old woman with stage IVB (cT3N3M1c) extensive disease small‐cell lung cancer was treated with carboplatin, etoposide, and atezolizumab. Ten days after pegfilgrastim initiation, during the second chemotherapy cycle, she experienced back pain. Contrast‐enhanced computed tomography r...

Full description

Bibliographic Details
Main Authors: Keisuke Shiraha, Yuki Takigawa, Akiko Sato, Keiichi Fujiwara, Yuka Matsuo, Mayu Goda, Tomoyoshi Inoue, Eri Nakamura, Miho Fujiwara, Suzuka Matsuoka, Hiromi Watanabe, Kenichiro Kudo, Ken Sato, Takuo Shibayama
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Respirology Case Reports
Subjects:
immune checkpoint inhibitor
immune‐related adverse event
large‐vessel vasculitis
pegfilgrastim
small‐cell lung cancer
Online Access:https://doi.org/10.1002/rcr2.1291

Internet

https://doi.org/10.1002/rcr2.1291

Similar Items